Half-year report · HY
7317.TEDINET S100X0JU
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥11.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.1bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥809m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥154m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥746m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥414m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥295m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥38m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥34m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥40.34 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.38 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.49 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.55 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.05 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥183m |
| Medical Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥975m |
| Safetysystemreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥254m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥25m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥152m |
| Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥924m |
| Safetysystemreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥265m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 475
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 3600000 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.1685 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 3165200 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.1481 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 2000000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0936 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 1880000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0880 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 987205 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0462 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 875800 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0410 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 800000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0374 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 400000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0187 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 338122 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0158 | |
| Number of shares held | InterimInstant | 17646327 | |
| Shareholding ratio | InterimInstant | 0.8257 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 4700 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21366500 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 213665 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 4400 | |
| Number of shares issued shares voting rights | InterimInstant | 21375600 | |
| Number of voting rights issued shares voting rights | InterimInstant | 213665 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 4700 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 4700 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0002 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 4700 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 4700 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0002 | |
| Cash and deposits | Prior1YearInstant | 4137356000 | JPY |
| Cash and deposits | InterimInstant | 4163315000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 1300782000 | JPY |
| Notes and accounts receivable trade and contract assets | InterimInstant | 1651577000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 6380000 | JPY |
| Electronically recorded monetary claims operating ca | InterimInstant | － | JPY |
| Merchandise and finished goods | Prior1YearInstant | 392847000 | JPY |
| Merchandise and finished goods | InterimInstant | 482177000 | JPY |
| Work in process | Prior1YearInstant | 155500000 | JPY |
| Work in process | InterimInstant | 194953000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 1274445000 | JPY |
| Raw materials and supplies | InterimInstant | 1056084000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |